8-KThe WireRoutine
Shareholder Vote
Filed Jun 22, 2026 · 8d ago · Accession 0001104659-26-076352
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ArriVent BioPharma, Inc.
- Ticker
- AVBP
- CIK
- 1868279
- Form type
- 8-K
- Filing date
- Jun 22, 2026
- Report date
- Jun 18, 2026
- Document
- tm2618466d1_8k.htm
- Size
- 196 KB